<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01255436</url>
  </required_header>
  <id_info>
    <org_study_id>GCS IM 2010-002 (R-006TE)</org_study_id>
    <nct_id>NCT01255436</nct_id>
  </id_info>
  <brief_title>Effectiveness of SMS Text Reminders to Improve Blood Pressure Among Patients With Hypertension</brief_title>
  <official_title>Effectiveness of SMS Text Reminders to Improve Blood Pressure Among Patients With Hypertension at a General Medicine Outpatient Clinic in a Tertiary Center in Manila, Philippines: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of the Philippines</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Health, Philippines</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of the Philippines</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To test the primary hypothesis that SMS text messages delivered to patients via
      mobile phone can improve blood pressure within 12 weeks compared to usual care

      Design: Parallel group, randomized, controlled trial; the patient is the unit of
      randomization

      Setting: General Medicine Outpatient Continuity Clinic of the Philippine General Hospital and
      Private Outpatient Clinics near the Philippine General Hospital

      Patients: Ambulatory men and women aged 19 years and older (N=700) with a diagnosis of
      essential hypertension, on maintenance blood pressure-lowering medications, who have daily
      access to a mobile phone in the household and know or live with someone who knows how to
      retrieve, read and reply to text messages using a mobile phone

      Intervention: SMS text messages delivered twice a week for 12 weeks, which aim to 1) provide
      information regarding hypertension; 2) remind patients to take their medications.

      Main Outcome Measure: The primary outcomes are the mean change in systolic and diastolic
      blood pressures at the end of 12 weeks. The secondary outcomes are improvement in blood
      pressure control rate and medication adherence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be done in 2 phases:

      Phase I: Development of the SMS text messages

      The SMS messages to be used in the trial will be developed and pre-tested in focus group
      discussions of a convenience sample of subjects similar to the target population for
      understandability and acceptability.

      Phase II: Parallel group, open-label, randomized, controlled trial

      Target Population

      Hypertensive patients being seen at the General Medicine Outpatient Clinic of a public,
      tertiary, university hospital in Manila, Philippines

      Sampling Method

      A criterion sampling strategy will be used in the study. Patients who fulfill the eligibility
      criteria will be recruited consecutively until the desired sample size is reached.

      Randomization and Allocation Concealment

      Eligible patients will be randomized to one of two treatment groups using a
      computer-generated random allocation sequence. Allocation of treatment will be done by a
      third party using sequential, sealed opaque envelopes.

      Blinding

      Given the nature of the intervention, patients will not be blinded to the treatment groups.
      However, measures will be taken to blind the physicians managing the participants at the
      clinic. Outcome assessors will also be blinded to the participants' treatment groups.

      Procedures and Measurements

      Written, informed consent will be obtained prior to enrolment in the study. Once an eligible
      participant has given consent, he will be randomized to either the intervention or control
      arm of the trial by a third party using sequentially numbered opaque envelopes. At the end of
      a 12-week follow up period, participants will be asked to return for a final study visit,
      where blood pressure and medication adherence will be measured. Acceptability of the SMS
      intervention will also be determined using a structured questionnaire. A period of four weeks
      from scheduled date of final visit is allowed before a patient is considered to have been
      lost to follow-up.

      Intervention: SMS reminders

      Patients in the intervention arm will receive 2 text messages per week delivered via SMS on
      randomly chosen days and times during the 12-week study period. The aims of the messages are
      to remind patients to take their blood pressure medications daily, what the target blood
      pressure is, and the benefits of daily intake of anti-hypertensive medications. Successful
      contact will be assumed when &quot;Message sent&quot; is seen on the screen. Otherwise, the same text
      message shall be immediately resent up to a maximum of 3 times. Receipt of the messages will
      be free to the study participants and independent of their telephone service provider.

      Control: Usual Care

      Routine or usual care of hypertensive patients at the General Medicine Outpatient clinic is
      based on the Seventh Report of the Joint National Committee on Prevention, Detection,
      Evaluation, and Treatment of High Blood Pressure. This consists of physician visits, advice
      and medication prescription by the healthcare provider. It does not include sending SMS
      messages to encourage adherence and provide information regarding hypertension.

      Outcome Measurements

      Blood Pressure

      Blood pressure will be measured using a calibrated digital sphygmomanometer manufactured by
      Omron after the participant has been seated quietly for five minutes. The average of two
      readings taken five minutes apart will be recorded.

      Medication Adherence

      The Adherence Self-Report Questionnaire (ASRQ), a brief, validated, self-administered
      questionnaire, will be used to measure medication adherence. Participants will be asked to
      complete the Filipino translation of the ASRQ.

      Acceptability of SMS Messages

      Acceptability of the SMS messages will be measured using a brief, self-administered
      questionnaire.

      Planned Analysis

      Descriptive statistics for baseline characteristics, adherence scores, and adherence rates in
      both groups (mean, sd, frequency (%), median) will be computed. Between-group comparisons
      will be done at baseline to check for similarity of baseline characteristics, and at the end
      of 12 weeks to test the hypothesis of inequality between two populations. All hypothesis
      tests will be one-sided with a level of significance set at 0.05. Intention-to-treat (ITT)
      analysis will be done, with possible sensitivity analysis for drop-outs. All statistical
      computations will be computed using the Stata statistical software.

      Sample Size

      The NCSS-PASS statistical software was used to compute for the desired sample size.

      The sample size required to fulfill the objectives of the study is 286 subjects per group.
      Allowing for a loss to follow up of approximately 20%, the final sample size is 350 subjects
      per group (total of 700 subjects).

      Ethical Considerations

      Ethics approval will be obtained prior to conducting this study. Written informed consent
      will be obtained from all participants prior to enrolment. Good clinical practice guidelines
      will be followed during the course of the study.

      At the beginning of the trial, it will be emphasised that communication through SMS in this
      study is one-way (provider to patient), so there will be no reply to any and all text
      messages received from participants. The participants will also be advised to consult their
      physicians for any problems they may experience.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Absolute Change in Systolic Blood Pressure After 12 Weeks</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>Absolute change in systolic blood pressure from baseline to 12 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Absolute Change in Diastolic Blood Pressure After 12 Weeks</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>Absolute change in diastolic blood pressure from baseline to 12 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence Rate</measure>
    <time_frame>12 weeks</time_frame>
    <description>The percentage of patients with an improvement of at least one point in adherence score as measured by the Adherence Self-Report Questionnaire at the end of 12 weeks Scale Range: 1 to 6, with 1 being the highest (most adherent) and 6 being the lowest (least adherent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Patients With Controlled Blood Pressure at the End of 12 Weeks</measure>
    <time_frame>12 weeks</time_frame>
    <description>The percentage of patients with systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHg at the end of 12 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">700</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>SMS text reminders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will receive SMS text messages on top of the usual care they receive from their physicians.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants in this arm will receive the usual care they receive from their physicians.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SMS text reminders</intervention_name>
    <description>Patients in the intervention arm will receive 2 text messages per week delivered via SMS on randomly chosen days and times during the 12-week study period. The aims of the messages are to remind patients to take their blood pressure medications daily, what the target blood pressure is, and the benefits of daily intake of anti-hypertensive medications.</description>
    <arm_group_label>SMS text reminders</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Patients in the usual care arm will receive the care usually provided by their physicians. This consists of consultations, medical advice, and prescriptions for maintenance medications. They will not be sent any SMS text reminders from the study.</description>
    <arm_group_label>Usual Care</arm_group_label>
    <other_name>No SMS text reminders</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory adult patients of both sexes with age at least 19 years old being seen at
             the General Medicine Outpatient Clinic of the Philippine General Hospital

          -  A diagnosis of hypertension in the medical record

          -  On at least 1 maintenance medication for hypertension for at least 1 month

          -  A systolic blood pressure greater than 129 mmHg and less than 160 mmHg or a diastolic
             blood pressure greater than 79 mmHg or less than 100 mmHg at the time of screening

          -  Patients with daily access to a mobile phone in the household

          -  Patients who live with someone who knows how to retrieve and read text messages on
             their mobile phone, and can relay these messages to them

          -  Written informed consent

        Exclusion Criteria:

          -  Participation in other studies within one month of trial initiation

          -  Patients who are unable or refuse to give informed consent

          -  Patients who have a clinical condition that might interfere with the study (dementia,
             psychological disorder)

          -  Patients who share a household with another patient who has already been recruited to
             participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lia M. Palileo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of the Philippines Manila</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Philippine General Hospital</name>
      <address>
        <city>Manila</city>
        <zip>1000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2010</study_first_submitted>
  <study_first_submitted_qc>December 6, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2010</study_first_posted>
  <results_first_submitted>August 31, 2012</results_first_submitted>
  <results_first_submitted_qc>August 31, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 2, 2012</results_first_posted>
  <last_update_submitted>January 6, 2017</last_update_submitted>
  <last_update_submitted_qc>January 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of the Philippines</investigator_affiliation>
    <investigator_full_name>Lia M. Palileo</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients with hypertension, maintained on blood pressure-lowering medications, who fulfilled the inclusion/exclusion criteria, and consulting at the General Medicine outpatient continuity clinic were recruited over a period of 6 months.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>SMS Text Reminders</title>
          <description>2 SMS text reminders per week for 12 weeks</description>
        </group>
        <group group_id="P2">
          <title>No SMS Text Reminders</title>
          <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="333">350 patients enrolled but 17 excluded because of missing baseline data.</participants>
                <participants group_id="P2" count="329">350 patients enrolled but 21 excluded because of missing baseline data</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="151"/>
                <participants group_id="P2" count="135"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="182"/>
                <participants group_id="P2" count="194"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="178"/>
                <participants group_id="P2" count="191"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death, stroke, or MI</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SMS Text Reminders</title>
          <description>2 SMS text reminders per week for 12 weeks</description>
        </group>
        <group group_id="B2">
          <title>No SMS Text Reminders</title>
          <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="333"/>
            <count group_id="B2" value="329"/>
            <count group_id="B3" value="662"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.0" spread="10.7"/>
                    <measurement group_id="B2" value="59.6" spread="11.1"/>
                    <measurement group_id="B3" value="59.3" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="220"/>
                    <measurement group_id="B2" value="212"/>
                    <measurement group_id="B3" value="432"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="230"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Employment Status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Unemployed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="242"/>
                    <measurement group_id="B2" value="238"/>
                    <measurement group_id="B3" value="480"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Employed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Retired</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Educational Attainment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>No formal education</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elementary</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High school</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="145"/>
                    <measurement group_id="B2" value="152"/>
                    <measurement group_id="B3" value="297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>College</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time in years since diagnosis of hypertension</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.5" spread="11.1"/>
                    <measurement group_id="B2" value="8.6" spread="8.2"/>
                    <measurement group_id="B3" value="8.5" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of prescribed drugs for hypertension</title>
          <units>medications</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="B2" value="2" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B3" value="2" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of prescribed maintenance medications</title>
          <units>medications</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="1" upper_limit="10"/>
                    <measurement group_id="B2" value="4" lower_limit="1" upper_limit="13"/>
                    <measurement group_id="B3" value="4" lower_limit="1" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Absolute Change in Systolic Blood Pressure After 12 Weeks</title>
        <description>Absolute change in systolic blood pressure from baseline to 12 weeks</description>
        <time_frame>baseline and 12 weeks</time_frame>
        <population>Only participants who completed follow up and had evaluable data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SMS Text Reminders</title>
            <description>2 SMS text reminders per week for 12 weeks</description>
          </group>
          <group group_id="O2">
            <title>No SMS Text Reminders</title>
            <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Absolute Change in Systolic Blood Pressure After 12 Weeks</title>
          <description>Absolute change in systolic blood pressure from baseline to 12 weeks</description>
          <population>Only participants who completed follow up and had evaluable data were analyzed.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="151"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-13.7" spread="19.1"/>
                    <measurement group_id="O2" value="-9.5" spread="25.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.06</p_value>
            <p_value_desc>p-value&lt;0.05 is considered significant</p_value_desc>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.4</ci_lower_limit>
            <ci_upper_limit>1.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Absolute Change in Diastolic Blood Pressure After 12 Weeks</title>
        <description>Absolute change in diastolic blood pressure from baseline to 12 weeks</description>
        <time_frame>baseline and 12 weeks</time_frame>
        <population>Only patients who completed follow up and had evaluable data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SMS Text Reminders</title>
            <description>2 SMS text reminders per week for 12 weeks</description>
          </group>
          <group group_id="O2">
            <title>No SMS Text Reminders</title>
            <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Absolute Change in Diastolic Blood Pressure After 12 Weeks</title>
          <description>Absolute change in diastolic blood pressure from baseline to 12 weeks</description>
          <population>Only patients who completed follow up and had evaluable data were analyzed.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="151"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.2" spread="11.1"/>
                    <measurement group_id="O2" value="-4.7" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.14</p_value>
            <p_value_desc>p-value &lt; 0.05 considered significant</p_value_desc>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.1</ci_lower_limit>
            <ci_upper_limit>1.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Adherence Rate</title>
        <description>The percentage of patients with an improvement of at least one point in adherence score as measured by the Adherence Self-Report Questionnaire at the end of 12 weeks Scale Range: 1 to 6, with 1 being the highest (most adherent) and 6 being the lowest (least adherent)</description>
        <time_frame>12 weeks</time_frame>
        <population>Only patients who completed follow up and had evaluable data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SMS Text Reminders</title>
            <description>2 SMS text reminders per week for 12 weeks</description>
          </group>
          <group group_id="O2">
            <title>No SMS Text Reminders</title>
            <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Adherence Rate</title>
          <description>The percentage of patients with an improvement of at least one point in adherence score as measured by the Adherence Self-Report Questionnaire at the end of 12 weeks Scale Range: 1 to 6, with 1 being the highest (most adherent) and 6 being the lowest (least adherent)</description>
          <population>Only patients who completed follow up and had evaluable data were analyzed.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="151"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.6"/>
                    <measurement group_id="O2" value="47.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.045</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.0</ci_lower_limit>
            <ci_upper_limit>1.6</ci_upper_limit>
            <estimate_desc>Numerator is Treatment Group (SMS reminders) and Denominator is Control Group (No SMS reminders)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Patients With Controlled Blood Pressure at the End of 12 Weeks</title>
        <description>The percentage of patients with systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHg at the end of 12 weeks</description>
        <time_frame>12 weeks</time_frame>
        <population>Only patients who completed follow up and had evaluable data were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>SMS Text Reminders</title>
            <description>2 SMS text reminders per week for 12 weeks</description>
          </group>
          <group group_id="O2">
            <title>No SMS Text Reminders</title>
            <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients With Controlled Blood Pressure at the End of 12 Weeks</title>
          <description>The percentage of patients with systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHg at the end of 12 weeks</description>
          <population>Only patients who completed follow up and had evaluable data were analyzed.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="151"/>
                <count group_id="O2" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2"/>
                    <measurement group_id="O2" value="54.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.014</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.04</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SMS Text Reminders</title>
          <description>2 SMS text reminders per week for 12 weeks</description>
        </group>
        <group group_id="E2">
          <title>No SMS Text Reminders</title>
          <description>Usual care consisting of clinic visits, physician advice and medication prescriptions</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="333"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="333"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>All-cause mortality</sub_title>
                <description>Cause of death unspecified.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="333"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="333"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="333"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Strong conclusions cannot be made because of the high attrition rate at the end of the study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Lia M. Palileo</name_or_title>
      <organization>University of the Philippines Manila</organization>
      <phone>6325679740</phone>
      <email>liapalileo@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

